Back
Rhythm Pharmaceuticals Stock Price Chart
Sponsored
RYTM
Sponsored
"EarnPhone": The Investment Hidden in Plain Sight
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
57
RYTM
Rhythm Pharmaceuticals
Last Price:
53.08
Seasonality Move:
11.04%
7 Day Trial
ALL ACCESS PASS
$
7
"The Next Apple?" - Mode's Growth Story is Turning Heads
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RYTM is experiencing slight selling pressure.
Rhythm Pharmaceuticals Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 49.38 | Buy |
20-day SMA: | 47.68 | Buy |
50-day SMA: | 47.5 | Buy |
200-day SMA: | 43.19 | Buy |
8-day EMA: | 49.08 | Buy |
20-day EMA: | 48.09 | Buy |
50-day EMA: | 46.65 | Buy |
200-day EMA: | 41.27 | Buy |
Rhythm Pharmaceuticals Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.91 | Buy |
Relative Strength Index (14 RSI): | 57.18 | Buy |
Chaikin Money Flow: | -131805 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (45.52 - 49.1) | Buy |
Bollinger Bands (100): | (39.32 - 48.12) | Buy |
Rhythm Pharmaceuticals Technical Analysis
Sep 3 | Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Rhythm Pharmaceuticals Stock
Is Rhythm Pharmaceuticals Stock a Buy?
- Rhythm Pharmaceuticals share price is 49.52 while RYTM 8-day simple moving average is 49.38, which is a Buy signal.
- The stock price of RYTM is 49.52 while Rhythm Pharmaceuticals 20-day SMA is 47.68, which makes it a Buy.
- Rhythm Pharmaceuticals 50-day simple moving average is 47.50 while RYTM share price is 49.52, making it a Buy technically.
- RYTM stock price is 49.52 and Rhythm Pharmaceuticals 200-day simple moving average is 43.19, creating a Buy signal.
RYTM Technical Analysis vs Fundamental Analysis
Buy
57
Rhythm Pharmaceuticals (RYTM)
is a Buy
Is Rhythm Pharmaceuticals a Buy or a Sell?
-
Rhythm Pharmaceuticals stock is rated a Buy
The current Rhythm Pharmaceuticals [RYTM] share price is $49.52. The Score for RYTM is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
Rhythm Pharmaceuticals Stock Info
Market Cap:
3.03B
Price in USD:
49.52
Share Volume:
350.22K
Rhythm Pharmaceuticals 52-Week Range
52-Week High:
53.92
52-Week Low:
20.97
Buy
57
Rhythm Pharmaceuticals (RYTM)
is a Buy
Rhythm Pharmaceuticals Share Price Forecast
-
What is the Rhythm Pharmaceuticals stock price today?
The Rhythm Pharmaceuticals stock price is 49.52 USD today. -
Will RYTM stock go up or go down?
Rhythm Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is Rhythm Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Rhythm Pharmaceuticals is not overvalued.
Is Rhythm Pharmaceuticals Stock a Buy?
- Rhythm Pharmaceuticals share price is 49.52 while RYTM 8-day exponential moving average is 49.08, which is a Buy signal.
- The stock price of RYTM is 49.52 while Rhythm Pharmaceuticals 20-day EMA is 48.09, which makes it a Buy.
- Rhythm Pharmaceuticals 50-day exponential moving average is 46.65 while RYTM share price is 49.52, making it a Buy technically.
- RYTM stock price is 49.52 and Rhythm Pharmaceuticals 200-day simple moving average is 41.27, creating a Buy signal.
Fundamental Analysis of Rhythm Pharmaceuticals
Is Rhythm Pharmaceuticals a good investment?
- Analysts estimate an earnings decrease this quarter of $0.11 per share, an increase next quarter of $0.24 per share, a decrease this year of $1.32 per share, and an increase next year of $1.68 per share.
Technical Analysis of Rhythm Pharmaceuticals
Should I short Rhythm Pharmaceuticals stock?
- RYTM Moving Average Covergence Divergence (MACD) indicator is 0.91, suggesting Rhythm Pharmaceuticals is a Buy
- Rhythm Pharmaceuticals Relative Strength Index (RSI) is 57.18, which suggest Rhythm Pharmaceuticals is overbought
- The Bollinger Bands (25) for Rhythm Pharmaceuticals is (45.52 - 49.1), which suggest Rhythm Pharmaceuticals is a Buy
- The Bollinger Bands (100) for Rhythm Pharmaceuticals is (39.32 - 48.12), which suggest Rhythm Pharmaceuticals is a Buy
* Rhythm Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.